))
Ep 21 | Thoughts on 340B & Biosimilar Uptake
Manage episode 365219868 series 3374171
Content provided by SpendMend Pharmacy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SpendMend Pharmacy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
54 episodes
Share
